Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Angiogenesis, Pathologic

ng-nitroarginine methyl ester has been researched along with Angiogenesis, Pathologic in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (21.57)18.2507
2000's23 (45.10)29.6817
2010's17 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geng, HL; Jin, MY; Lu, MQ; Wei, J; Xiong, ZH1
Fang, ZH; Gao, JR; Guo, MF; Han, LP; Jiang, NN; Qin, XJ1
Shang, ZJ; Song, K; Song, Y; Zhao, XP1
Freitas, C; Grutzendler, J; Whiteus, C1
Dinya, E; Fazekas, A; Gyorfi, A; Gyurkovics, M; Lohinai, Z; Rosivall, L; Székely, DA1
Lu, A; Qian, L; Wang, L1
Gao, Y; Guo, ZT; Huang, Q; Li, P; Pan, WK1
Choi, MJ; Jin, HR; Jung, K; Kim, WJ; Koh, GY; Koh, YJ; Kwon, MH; Lee, SW; Piao, S; Ryu, JK; Shin, HY; Suh, JK1
Doerschuk, CM; Faber, JE; Maeda, N; Moore, SM; Zhang, H1
Cai, B; Cai, W; Deng, P; Guan, Y; Schaper, J; Schaper, W; Wu, X; Yang, B; Zhang, B1
Bai, YY; Ding, J; Ju, SH; Li, PC; Li, ZH; Lu, CQ; Peng, XG; Wang, LS; Wang, YC; Zhao, Z1
Derakhshan, B; Harrison, KD; Miao, QR; Sessa, WC1
Cai, XH; Chen, J; Chen, YF; Du, L; Huang, S; Mei, K; Yin, XD; Yu, JR; Zhang, ZX; Zhao, X; Zhou, CY1
Fujita, M; Hattori, M; Kishimoto, C; Mikami, Y; Okabe, TA; Shimada, K1
Banerjee, R; Kumar, JM; Reddy, BS; Roy, S; Sudhakar, G1
Bisland, SK; Flitney, FW; Fricker, SP; Hirst, DG; Kennovin, GD; Pritchard, RJ1
Anand-Apte, B; Ebrahem, Q; Morais, C; Parat, MO1
Amin, A; Badr El-Din, NK; Choi, SK; Kadowitz, P; Kevil, CG; Matrougui, K; Navar, LG; Osman-Elazeik, Y; Trebak, M1
Harada, N; Hata, H; Matsuno, F; Matsuzaki, H; Mitsuya, H; Mitsuya, Y; Nagasaki, A; Uneda, S1
Chakraborty, C; Jadeski, LC; Lala, PK1
Akita, T; Duan, J; Egami, K; Ikeda, H; Imaizumi, T; Murohara, T; Sasaki, K; Shimada, T; Shintani, S1
Harada, M; Kitaura, Y; Komuro, I; Masaya, M; Minamino, T; Nagai, T; Sugaya, T; Terasaki, F; Toko, H; Zou, Y1
Miyoshi, C; Ohshima, N; Taguchi, E1
Fan, TP; Koolwijk, P; Leung, HW; Sasisekharan, R; Sellers, LA; Sengupta, S; Skepper, JN; Toh, SA; Wong, RN; Yeung, HW1
Deblois, D; Girardot, D; Jover, B; Moles, JP; Moreau, P1
Corrêa, FM; Cunha, FQ; de Oliveira, AM; Fukada, SY; Iyomasa, MM1
Latacha, KS; Rosenquist, TH1
Diamond, MP; Malone, JM; Munkarah, AR; Saed, GM; Sokol, RJ1
Ho, YS; Kim, KE; Kim, YM; Koh, GY; Lee, KJ1
Appleton, I; Clarkson, AN; Jackson, DM; Liu, H; Sammut, IA; Schiborra, F; Shaw, O1
Han, DW; Ji, C; Ji, JQ; Li, BH; Su, AR; Zhang, HY; Zhang, LT; Zhao, ZF1
Barchowsky, A; Basu, P; Ghosh, RN; Grove, LE; Klei, L1
Fong, TW; Harlow, LA; Koch, AE; Leibovich, SJ; Polverini, PJ1
Andriopoulou, P; Haralabopoulos, G; Maragoudakis, ME; Peristeris, P; Pipili-Synetos, E; Sakkoula, E1
Amerini, S; Geppetti, P; Granger, HJ; Ledda, F; Maggi, CA; Masini, E; Morbidelli, L; Ziche, M1
Ledda, F; Morbidelli, L; Parenti, A; Ziche, M1
Dimopoulos, J; Hatjikondi, O; Kardamakis, D; Papaioannou, S; Ravazoula, P1
Maragoudakis, ME; Pipili-Synetos, E; Sakkoula, E1
Fini-Storchi, I; Franchi, A; Gallo, O; Masini, E; Morbidelli, L; Vergari, WA; Ziche, M1
Davel, LE; De Lustig, ES; Eijan, AM; Jasnis, MA; Rozenberg, G; Rueda, HA1
Jadeski, LC; Lala, PK1
Cho, CH; Li, Y1
Chishima, S; Egashira, K; Katoh, M; Mitsui, T; Narita, H; Takeshita, A1
Chakraborty, C; Hum, KO; Jadeski, LC; Lala, PK1
Bernátová, I; Okruhlicová, L; Pechánová, O; Tribulová, N1
Cho, CH; Li, Y; Wang, HY; Wang, WP1
Raulais, D; Souttou, B; Vigny, M1
Eichler, W; Friedrichs, U; Hoffmann, S; Uhlmann, S; Wiedemann, P1
D'Agostino, A; Davel, L; De Lustig, ES; Eijan, AM; Español, A; Jasnis, MA; Lauría, L; Piccardo, I; Sales, ME1
Durie, M; Levy, BI; Silvestre, JS; Tamarat, R1
Andrade, SP; Hart, IR; Piper, PJ1

Other Studies

51 other study(ies) available for ng-nitroarginine methyl ester and Angiogenesis, Pathologic

ArticleYear
Protective effect of human umbilical cord mesenchymal stem cell exosomes on preserving the morphology and angiogenesis of placenta in rats with preeclampsia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 105

    Topics: Animals; Apoptosis; Blood Pressure; Cell Differentiation; Exosomes; Female; Humans; In Situ Nick-End Labeling; Mesenchymal Stem Cells; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Placenta; Pre-Eclampsia; Pregnancy; Protective Agents; Rats; Umbilical Cord; Vascular Endothelial Growth Factor A

2018
To Explore the Pathogenesis of Vascular Lesion of Type 2 Diabetes Mellitus Based on the PI3K/Akt Signaling Pathway.
    Journal of diabetes research, 2019, Volume: 2019

    Topics: Animals; Aorta, Abdominal; Blood Glucose; Blood Pressure; Chronic Disease; Diabetes Mellitus, Type 2; Glycosylation; Heart Rate; Human Umbilical Vein Endothelial Cells; Humans; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Phosphatidylinositol 3-Kinases; Phosphorylation; Prognosis; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Treatment Outcome

2019
Ephrin-A1 is up-regulated by hypoxia in cancer cells and promotes angiogenesis of HUVECs through a coordinated cross-talk with eNOS.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Chromones; Coculture Techniques; Enzyme Inhibitors; Ephrin-A1; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Morpholines; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction

2013
Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period.
    Nature, 2014, Jan-16, Volume: 505, Issue:7483

    Topics: Animals; Animals, Newborn; Blood Vessels; Capillaries; Cell Proliferation; Cerebral Cortex; Cerebrovascular Circulation; Dendritic Spines; Endothelial Cells; Female; Hypoxia, Brain; Interneurons; Male; Mice; Microcirculation; Neovascularization, Pathologic; Neovascularization, Physiologic; Neuroglia; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Signal Transduction; Time Factors; Vibrissae

2014
[Investigation of the venodilatory effect of vascular endothelial growth factor (VEGF) in rat gingiva].
    Fogorvosi szemle, 2013, Volume: 106, Issue:2

    Topics: Animals; Capillary Permeability; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gingiva; Immunohistochemistry; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Quinazolines; Rats; Rats, Wistar; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vasodilation; Venules

2013
The role of eNOS in the migration and proliferation of bone-marrow derived endothelial progenitor cells and in vitro angiogenesis.
    Cell biology international, 2015, Volume: 39, Issue:4

    Topics: Animals; Bone Marrow Cells; Cell Movement; Cell Proliferation; Endothelial Progenitor Cells; Lipoproteins, LDL; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptors, CXCR; Receptors, CXCR4; Vascular Endothelial Growth Factor Receptor-2

2015
Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:8

    Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Chromones; Cinnamates; Cyclin A2; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p21; Endothelial Cells; Hemangioma; Humans; Infant; Infant, Newborn; Morpholines; Neoplasm Invasiveness; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Norepinephrine; Pericytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proliferating Cell Nuclear Antigen; Propranolol; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2015
Designed angiopoietin-1 variant, COMP-angiopoietin-1, rescues erectile function through healthy cavernous angiogenesis in a hypercholesterolemic mouse.
    Scientific reports, 2015, Mar-18, Volume: 5

    Topics: Animals; Cells, Cultured; Cyclic GMP; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Endothelial Cells; Histone Deacetylase 2; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Penile Erection; Penis; Phosphorylation; Recombinant Fusion Proteins; Regional Blood Flow; Tight Junction Proteins

2015
Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury.
    Angiogenesis, 2015, Volume: 18, Issue:3

    Topics: Animals; Cardiovascular Diseases; Cell Proliferation; Collateral Circulation; Female; Hindlimb; Immunohistochemistry; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Physical Conditioning, Animal; Quinolines; Renin; Risk Factors; Time Factors

2015
Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Animals; Antigens, CD; Cadherins; Capillary Permeability; Cell Culture Techniques; Enzyme Inhibitors; Femoral Artery; Gene Expression Regulation; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Macrophages; Myocytes, Smooth Muscle; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroso Compounds; Rats; Rats, Sprague-Dawley; Signal Transduction

2015
Bone Marrow Endothelial Progenitor Cell Transplantation After Ischemic Stroke: An Investigation Into Its Possible Mechanism.
    CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:11

    Topics: Animals; Bone Marrow Transplantation; Brain-Derived Neurotrophic Factor; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Endothelial Progenitor Cells; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Nervous System Diseases; Neurogenesis; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphopyruvate Hydratase; Time Factors

2015
Approaches for studying angiogenesis-related signal transduction.
    Methods in enzymology, 2008, Volume: 443

    Topics: Animals; Enzyme-Linked Immunosorbent Assay; Humans; Luminescence; Neovascularization, Pathologic; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrites; Signal Transduction; Vascular Endothelial Growth Factor A

2008
[Effect of nitric oxide derived from endothelial nitric oxide synthase on tumor angiogenesis].
    Chinese journal of cancer, 2010, Volume: 29, Issue:1

    Topics: AC133 Antigen; Animals; Antigens, CD; Carcinoma, Lewis Lung; Cell Count; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoproteins; Mice; Mice, Inbred C57BL; Microvessels; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peptides; Plasmids; Random Allocation; Stem Cells; Transfection; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2010
Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide.
    Journal of molecular and cellular cardiology, 2010, Volume: 49, Issue:3

    Topics: Acute Disease; Animals; Autoimmune Diseases; Cardiac Myosins; Chronic Disease; Cytokines; Echocardiography; Enzyme Inhibitors; Granulocyte Colony-Stimulating Factor; Humans; Immunization; Immunoenzyme Techniques; Myocarditis; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred Lew; Recombinant Proteins; Superoxides; Swine

2010
17β-estradiol-linked nitro-L-arginine as simultaneous inducer of apoptosis in melanoma and tumor-angiogenic vascular endothelial cells.
    Molecular pharmaceutics, 2011, Apr-04, Volume: 8, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Female; Fibroblasts; Flow Cytometry; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitroarginine; Skin

2011
Antitumor actions of ruthenium(III)-based nitric oxide scavengers and nitric oxide synthase inhibitors.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:9

    Topics: Animals; Enzyme Inhibitors; Free Radical Scavengers; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organometallic Compounds; Pentetic Acid; Rats; Ruthenium; Sarcoma, Experimental; Transplantation, Isogeneic; Tumor Burden

2011
Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.
    The American journal of pathology, 2012, Volume: 180, Issue:4

    Topics: Animals; Caveolin 1; Cells, Cultured; Chemotaxis; Corneal Neovascularization; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Lung; Melanoma, Experimental; Mice; Mice, Knockout; Neoplasm Transplantation; Neovascularization, Pathologic; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Vascular Endothelial Growth Factor A

2012
Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension.
    Pflugers Archiv : European journal of physiology, 2012, Volume: 464, Issue:6

    Topics: Allopurinol; Angiotensin II; Animals; Arterial Pressure; Capillaries; Cyclic AMP; Cyclic GMP; Femoral Artery; Hindlimb; Hypertension; Indoles; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Sodium Nitrite; Xanthine Dehydrogenase

2012
A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model.
    British journal of haematology, 2003, Volume: 120, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Endothelial Growth Factors; Female; Intercellular Signaling Peptides and Proteins; Lymphokines; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasmacytoma; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
    International journal of cancer, 2003, Sep-10, Volume: 106, Issue:4

    Topics: Animals; Apoptosis; Cell Cycle; Cell Movement; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Tumor Cells, Cultured

2003
Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation.
    Journal of the American College of Cardiology, 2003, Jul-16, Volume: 42, Issue:2

    Topics: Administration, Oral; Animals; Cholesterol; Cholesterol, HDL; Cyclic GMP; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Folic Acid; Hindlimb; Homocysteine; Hypercholesterolemia; Ischemia; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peripheral Vascular Diseases; Rats; Rats, Sprague-Dawley; Risk Factors; Severity of Illness Index

2003
Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:4

    Topics: Angiotensin II; Animals; Arterioles; Capillaries; Chemotaxis, Leukocyte; Collateral Circulation; Cytokines; Enzyme Inhibitors; Granulocytes; Macrophages; Male; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Sarcoma 180; T-Lymphocytes; Ventricular Remodeling

2004
Leukocyte behavior in angiogenic vessels is affected by tumor-derived nitric oxide.
    The Japanese journal of physiology, 2003, Volume: 53, Issue:5

    Topics: Animals; Cell Adhesion; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Fluorescein; Fluorescent Dyes; Hemodynamics; Leukocytes; Male; Mesentery; Microcirculation; Microscopy, Confocal; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peritoneal Neoplasms; Rats; Rats, Inbred F344

2003
Modulating angiogenesis: the yin and the yang in ginseng.
    Circulation, 2004, Sep-07, Volume: 110, Issue:10

    Topics: Americas; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Cells, Cultured; China; Drug Implants; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Ginsenosides; Humans; Korea; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Panax; Phosphatidylinositol 3-Kinases; Phytotherapy; Signal Transduction; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Surgical Sponges; Umbilical Veins

2004
Chronic nitric oxide synthase inhibition prevents new coronary capillary generation.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3

    Topics: Administration, Oral; Animals; Aorta; Blood Pressure; Body Mass Index; Body Weight; Capillaries; Cardiac Volume; Cardiomyopathy, Hypertrophic; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Heart; Heart Ventricles; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Penicillamine; Rats; Rats, Wistar; Ventricular Remodeling

2004
Mechanisms of impaired vascular response to ANG II in perivascular injured carotid arteries of ovariectomized rat.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3

    Topics: Angiotensin II; Animals; Calcium; Carotid Artery Injuries; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Imidazoles; Implants, Experimental; Indomethacin; Muscle, Smooth, Vascular; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ovariectomy; Photomicrography; Pyridines; Rabbits; Rats; Rats, Wistar; Silicones; Time Factors; Vasoconstriction

2004
Homocysteine inhibits extra-embryonic vascular development in the avian embryo.
    Developmental dynamics : an official publication of the American Association of Anatomists, 2005, Volume: 234, Issue:2

    Topics: Animals; Birds; Cell Survival; Cells, Cultured; Chick Embryo; Dose-Response Relationship, Drug; Embryonic Development; Endothelium, Vascular; Homocysteine; Humans; Immunohistochemistry; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxazines; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Time Factors; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A

2005
The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
    American journal of obstetrics and gynecology, 2006, Volume: 194, Issue:4

    Topics: Cell Line, Tumor; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Ovarian Neoplasms; Umbilical Veins

2006
Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis.
    Cancer research, 2006, Jun-15, Volume: 66, Issue:12

    Topics: Angiopoietin-1; Animals; Catalase; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Endothelial Cells; Humans; Hydrogen Peroxide; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Phosphorylation; Proto-Oncogene Proteins c-akt

2006
Angiogenesis as a predictive marker of neurological outcome following hypoxia-ischemia.
    Brain research, 2007, Sep-26, Volume: 1171

    Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Biomarkers; Brain; Chlormethiazole; Enzyme Inhibitors; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Hypoxia-Ischemia, Brain; Interleukin-1beta; Male; Neovascularization, Pathologic; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Platelet Endothelial Cell Adhesion Molecule-1; Predictive Value of Tests; Rats; Rats, Wistar

2007
Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
    World journal of gastroenterology, 2007, Dec-21, Volume: 13, Issue:47

    Topics: Alanine Transaminase; Animals; Bronchoalveolar Lavage Fluid; Capillaries; Carboxyhemoglobin; Cytokines; Disease Progression; Endotoxemia; Enzyme Inhibitors; Guanidines; Heme Oxygenase (Decyclizing); Hepatopulmonary Syndrome; Intestinal Diseases; Lipopolysaccharides; Liver; Liver Cirrhosis, Experimental; Lung; Male; Malondialdehyde; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Portal Pressure; Protoporphyrins; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Up-Regulation

2007
Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (roxarsone).
    Environmental health perspectives, 2008, Volume: 116, Issue:4

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphorylation; Polymerase Chain Reaction; Roxarsone

2008
Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, May-10, Volume: 91, Issue:10

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cells, Cultured; Chemotaxis; Cornea; Culture Media, Conditioned; Endothelium, Vascular; Endotoxins; Humans; Interleukin-8; Lipopolysaccharides; Monocytes; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Stereoisomerism; Tumor Necrosis Factor-alpha; Umbilical Veins

1994
Evidence that nitric oxide is an endogenous antiangiogenic mediator.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: Allantois; Animals; Arginine; Chick Embryo; Chorion; Cyclic GMP; Dexamethasone; Drug Interactions; Endothelium, Vascular; Humans; Models, Biological; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Thrombin

1994
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
    The Journal of clinical investigation, 1994, Volume: 94, Issue:5

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Division; Cell Movement; Cells, Cultured; Cyclic GMP; DNA; Endothelium, Vascular; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Platelet Aggregation; Rabbits; Substance P

1994
Nitric oxide modulates angiogenesis elicited by prostaglandin E1 in rabbit cornea.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Alprostadil; Amino Acid Oxidoreductases; Animals; Arginine; Cornea; Coronary Vessels; Morphogenesis; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Rabbits; Stereoisomerism

1995
In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity.
    British journal of cancer, 1996, Volume: 74, Issue:12

    Topics: Animals; Arginine; Chick Embryo; Chorion; Enzyme Inhibitors; Microcirculation; Neovascularization, Pathologic; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; X-Ray Therapy

1996
Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2.
    British journal of pharmacology, 1997, Volume: 122, Issue:5

    Topics: Allantois; Animals; Cells, Cultured; Chick Embryo; Chorion; Endothelium, Vascular; Enzyme Inhibitors; Humans; Interleukin-2; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Umbilical Veins

1997
Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.
    Journal of the National Cancer Institute, 1998, Apr-15, Volume: 90, Issue:8

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Cyclic GMP; Disease Progression; Enzyme Inhibitors; Female; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Transcription, Genetic; Tumor Cells, Cultured

1998
Differential nitric oxide release and sensitivity to injury in different murine mammary tumor cell lines.
    International journal of molecular medicine, 1998, Volume: 2, Issue:5

    Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Interferon-gamma; Lipopolysaccharides; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside

1998
Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors.
    The American journal of pathology, 1999, Volume: 155, Issue:4

    Topics: Animals; Coloring Agents; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Female; Immunohistochemistry; Macrophages; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet Endothelial Cell Adhesion Molecule-1; Tumor Cells, Cultured

1999
The ulcer healing effect of protamine sulphate in rat stomach.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:10

    Topics: Animals; Cell Division; Enzyme Activation; Epidermal Growth Factor; Fibroblast Growth Factor 2; Gastric Mucosa; Heparin Antagonists; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protamines; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Tumor Necrosis Factor-alpha

1999
Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Coronary Vessels; Enzyme Inhibitors; Gene Expression; Heart Rate; Hydralazine; Imidazoles; Imidazolidines; Immunoenzyme Techniques; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred WKY; Tissue Plasminogen Activator

2000
Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.
    International journal of cancer, 2000, Apr-01, Volume: 86, Issue:1

    Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Division; Cell Movement; Enzyme Inhibitors; Female; Immunohistochemistry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Tumor Cells, Cultured

2000
Induction of angiogenesis in NO-deficient rat heart.
    Physiological research, 2000, Volume: 49, Issue:1

    Topics: Animals; Capillaries; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Fibroblasts; Heart Ventricles; Hypertension; Male; Microscopy, Electron; Myocardium; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar

2000
Intragastric administration of heparin enhances gastric ulcer healing through a nitric oxide-dependent mechanism in rats.
    European journal of pharmacology, 2000, Jul-07, Volume: 399, Issue:2-3

    Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Gastric Mucosa; Gene Expression Regulation, Enzymologic; Heparin; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stomach Ulcer

2000
Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways.
    Journal of cellular physiology, 2001, Volume: 187, Issue:1

    Topics: Androstadienes; Animals; Carrier Proteins; Cell Division; Cell Line; Cell Movement; Cells, Cultured; Cytokines; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Lymphokines; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Rats; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wortmannin

2001
Direct measurement of VEGF-induced nitric oxide production by choroidal endothelial cells.
    Microvascular research, 2001, Volume: 62, Issue:2

    Topics: Aged; Animals; Cattle; Cells, Cultured; Choroid; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Humans; Lymphokines; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; S-Nitroso-N-Acetylpenicillamine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilator Agents

2001
Reactivity of tumor-draining lymph nodes and the nitric oxide pathway.
    International journal of oncology, 2002, Volume: 20, Issue:1

    Topics: Adenocarcinoma; Animals; Enzyme Inhibitors; Immunoblotting; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III

2002
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.
    Laboratory investigation; a journal of technical methods and pathology, 2002, Volume: 82, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies, Monoclonal; Benzimidazoles; Biphenyl Compounds; Collagen; Cyclooxygenase 2; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Endothelial Growth Factors; Female; Imidazoles; Isoenzymes; Laminin; Lymphokines; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides; Tetrazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
    British journal of pharmacology, 1992, Volume: 107, Issue:4

    Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Colonic Neoplasms; Male; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostheses and Implants; Regional Blood Flow

1992